• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • RevImmune Advances New COVID-19 Immunotherapy americanpharmaceuticalreview
    November 04, 2020
    RevImmune announced its "ILIAD-7" international randomized controlled Phase 2 trial in patients critically ill with COVID-19, is now enrolling patients at five sites in the U.S.
  • RevImmune Announces Phase II Trial of the T-Cell Growth Factor for COVID-19 americanpharmaceuticalreview
    July 08, 2020
    RevImmune has launched the "ILIAD" Phase II trial for treatment of COVID-19.Many COVID-19 clinical trials have focused on decreasing the hyper-inflammatory phase that often occurs in COVID-19 patients and can cause substantial damage.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service